Astellas Joint Research Of Tropical Diseases Using KEK Synchrotron Radiation
This article was originally published in PharmAsia News
Executive Summary
High Energy Accelerator Research Organization KEK and Astellas Pharmaceuticals have signed an agreement to jointly conduct research aimed at discovering drugs for neglected tropical diseases.